222 related articles for article (PubMed ID: 23853004)
1. Acceptability of different oral formulations in infants and preschool children.
van Riet-Nales DA; de Neef BJ; Schobben AF; Ferreira JA; Egberts TC; Rademaker CM
Arch Dis Child; 2013 Sep; 98(9):725-31. PubMed ID: 23853004
[TBL] [Abstract][Full Text] [Related]
2. Methods of administering oral formulations and child acceptability.
van Riet-Nales DA; Ferreira JA; Schobben AF; de Neef BJ; Egberts TC; Rademaker CM
Int J Pharm; 2015 Aug; 491(1-2):261-7. PubMed ID: 26143234
[TBL] [Abstract][Full Text] [Related]
3. Favorable acceptance of mini-tablets compared with syrup: a randomized controlled trial in infants and preschool children.
Klingmann V; Spomer N; Lerch C; Stoltenberg I; Frömke C; Bosse HM; Breitkreutz J; Meissner T
J Pediatr; 2013 Dec; 163(6):1728-1732.e1. PubMed ID: 23972645
[TBL] [Abstract][Full Text] [Related]
4. Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: A randomized controlled trial.
Münch J; Meissner T; Mayatepek E; Wargenau M; Breitkreutz J; Bosse HM; Klingmann V
Eur J Pharm Biopharm; 2021 Sep; 166():126-134. PubMed ID: 34153451
[TBL] [Abstract][Full Text] [Related]
5. Pediatric Oral Formulations: An Updated Review of Commercially Available Pediatric Oral Formulations Since 2007.
Strickley RG
J Pharm Sci; 2019 Apr; 108(4):1335-1365. PubMed ID: 30447227
[TBL] [Abstract][Full Text] [Related]
6. Acceptability of multiple coated mini-tablets in comparison to syrup in infants and toddlers: a randomised controlled study.
Klingmann V; Hinder M; Langenickel TH; Chen F; Khder Y; Breitkreutz J; Bosse HM
Arch Dis Child; 2023 Sep; 108(9):730-735. PubMed ID: 36963813
[TBL] [Abstract][Full Text] [Related]
7. [Oral dosage forms for children: acceptability and palatability].
Kojima J
Yakugaku Zasshi; 2015; 135(2):245-7. PubMed ID: 25747220
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
9. Acceptability of Multiple Uncoated Minitablets in Infants and Toddlers: A Randomized Controlled Trial.
Klingmann V; Linderskamp H; Meissner T; Mayatepek E; Moeltner A; Breitkreutz J; Bosse HM
J Pediatr; 2018 Oct; 201():202-207.e1. PubMed ID: 29960767
[TBL] [Abstract][Full Text] [Related]
10. Solid oral forms availability in children: a cost saving investigation.
Lajoinie A; Henin E; Kassai B; Terry D
Br J Clin Pharmacol; 2014 Nov; 78(5):1080-9. PubMed ID: 24965935
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of Uncoated Mini-Tablets in Neonates--A Randomized Controlled Trial.
Klingmann V; Seitz A; Meissner T; Breitkreutz J; Moeltner A; Bosse HM
J Pediatr; 2015 Oct; 167(4):893-896.e2. PubMed ID: 26259675
[TBL] [Abstract][Full Text] [Related]
12. Age-Appropriate Pediatric Dosage Forms in Japan: Insights into End-User Perceptions From an Observational Cross-Sectional Survey Assessing the Acceptability of Oral Formulation.
Saito J; Akabane M; Komura M; Nakamura H; Ishikawa Y
Ther Innov Regul Sci; 2019 Jul; 53(4):455-471. PubMed ID: 30157669
[TBL] [Abstract][Full Text] [Related]
13. Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children.
Bélard S; Ramharter M; Kurth F
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD009568. PubMed ID: 33289099
[TBL] [Abstract][Full Text] [Related]
14. Ranitidine (Zantac) syrup versus Ranitidine effervescent tablets (Zantac) EFFERdose) in children: a single-center taste preference study.
Ameen VZ; Pobiner BF; Giguere GC; Carter EG
Paediatr Drugs; 2006; 8(4):265-70. PubMed ID: 16898856
[TBL] [Abstract][Full Text] [Related]
15. Evidence of acceptability of oral paediatric medicines: a review.
Mistry P; Batchelor H;
J Pharm Pharmacol; 2017 Apr; 69(4):361-376. PubMed ID: 27524471
[TBL] [Abstract][Full Text] [Related]
16. Pediatric drugs--a review of commercially available oral formulations.
Strickley RG; Iwata Q; Wu S; Dahl TC
J Pharm Sci; 2008 May; 97(5):1731-74. PubMed ID: 17823956
[TBL] [Abstract][Full Text] [Related]
17. Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects.
van Riet-Nales DA; Schobben AF; Vromans H; Egberts TC; Rademaker CM
Arch Dis Child; 2016 Jul; 101(7):662-9. PubMed ID: 26979250
[TBL] [Abstract][Full Text] [Related]
18. A survey of caregivers of Nigerian children less than 6 years of age to determine the experience and perception of acceptability of oral solid dosage forms.
Orubu S; Okwelogu C; Opanuga O; Tuleu C
Int J Pharm; 2018 Feb; 536(2):582-589. PubMed ID: 29100913
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
20. Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study.
Spomer N; Klingmann V; Stoltenberg I; Lerch C; Meissner T; Breitkreutz J
Arch Dis Child; 2012 Mar; 97(3):283-6. PubMed ID: 22253279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
